These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 27757707)
1. Platelet-Activating Factor Quantification Using Reversed Phase Liquid Chromatography and Selected Reaction Monitoring in Negative Ion Mode. Pike DP; Hartman CL; Weissler GJ; Palladino EN; Albert CJ; Ford DA Lipids; 2016 Dec; 51(12):1421-1425. PubMed ID: 27757707 [TBL] [Abstract][Full Text] [Related]
2. Development of a high-performance liquid chromatographic-mass spectrometric technique, with an ionspray interface, for the determination of platelet-activating factor (PAF) and lyso-PAF in biological samples. Silvestro L; Da Col R; Scappaticci E; Libertucci D; Biancone L; Camussi G J Chromatogr; 1993 Sep; 647(2):261-9. PubMed ID: 8227267 [TBL] [Abstract][Full Text] [Related]
3. Negative ion electrospray and tandem mass spectrometric analysis of platelet activating factor (PAF) (1-hexadecyl-2-acetyl-glycerophosphocholine). Harrison KA; Clay KL; Murphy RC J Mass Spectrom; 1999 Apr; 34(4):330-5. PubMed ID: 10226361 [TBL] [Abstract][Full Text] [Related]
4. Determination of 1-O-acyl-2-acetyl-sn-glyceryl-3-phosphorylcholine, platelet-activating factor and related phospholipids in biological samples by high-performance liquid chromatography--tandem mass spectrometry. Savu SR; Silvestro L; Sörgel F; Montrucchio G; Lupia E; Camussi G J Chromatogr B Biomed Appl; 1996 Jun; 682(1):35-45. PubMed ID: 8832423 [TBL] [Abstract][Full Text] [Related]
5. Identification and quantitation of changes in the platelet activating factor family of glycerophospholipids over the course of neuronal differentiation by high-performance liquid chromatography electrospray ionization tandem mass spectrometry. Whitehead SN; Hou W; Ethier M; Smith JC; Bourgeois A; Denis R; Bennett SA; Figeys D Anal Chem; 2007 Nov; 79(22):8539-48. PubMed ID: 17949058 [TBL] [Abstract][Full Text] [Related]
7. Molecular heterogeneity of PAF in normal human mixed saliva: quantitative mass spectral analysis after direct derivatization of PAF with pentafluorobenzoic anhydride. Woodard DS; Mealey BL; Lear CS; Satsangi RK; Prihoda TJ; Weintraub ST; Pinckard RN; McManus LM Biochim Biophys Acta; 1995 Nov; 1259(2):137-47. PubMed ID: 7488633 [TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of platelet activating factor using fast atom bombardment/tandem mass spectrometry. Haroldsen PE; Gaskell SJ Biomed Environ Mass Spectrom; 1989 Jun; 18(6):439-44. PubMed ID: 2504312 [TBL] [Abstract][Full Text] [Related]
9. Quantification of distinct molecular species of the 2-lyso metabolite of platelet-activating factor by gas chromatography-negative-ion chemical ionization mass spectrometry. Turk J; Bohrer A; Stump WT; Ramanadham S; Mangino MJ J Chromatogr; 1992 Mar; 575(2):183-96. PubMed ID: 1629294 [TBL] [Abstract][Full Text] [Related]
10. Structure elucidation of platelet activating factor derived from human neutrophils. Clay KL; Murphy RC; Andres JL; Lynch J; Henson PM Biochem Biophys Res Commun; 1984 Jun; 121(3):815-25. PubMed ID: 6430285 [TBL] [Abstract][Full Text] [Related]
11. Molecular species of platelet-activating factor generated by human neutrophils challenged with ionophore A23187. Oda M; Satouchi K; Yasunaga K; Saito K J Immunol; 1985 Feb; 134(2):1090-3. PubMed ID: 3917470 [TBL] [Abstract][Full Text] [Related]
12. Molecular heterogeneity of platelet-activating factor produced by stimulated human polymorphonuclear leukocytes. Pinckard RN; Jackson EM; Hoppens C; Weintraub ST; Ludwig JC; McManus LM; Mott GE Biochem Biophys Res Commun; 1984 Jul; 122(1):325-32. PubMed ID: 6743335 [TBL] [Abstract][Full Text] [Related]
13. Quantitation of platelet-activating factor in biological samples using liquid chromatography/mass spectrometry with column-switching technique. Oda Y; Mano N; Asakawa N Anal Biochem; 1995 Oct; 231(1):141-50. PubMed ID: 8678293 [TBL] [Abstract][Full Text] [Related]
14. Stress-induced platelet-activating factor synthesis in human neutrophils. Owen JS; Baker PR; O'Flaherty JT; Thomas MJ; Samuel MP; Wooten RE; Wykle RL Biochim Biophys Acta; 2005 Apr; 1733(2-3):120-9. PubMed ID: 15863359 [TBL] [Abstract][Full Text] [Related]
15. Fast atom bombardment-mass spectrometric identification of molecular species of platelet-activating factor produced by stimulated human polymorphonuclear leukocytes. Weintraub ST; Ludwig JC; Mott GE; McManus LM; Lear C; Pinckard RN Biochem Biophys Res Commun; 1985 Jun; 129(3):868-76. PubMed ID: 4015656 [TBL] [Abstract][Full Text] [Related]
16. An improved assay for platelet-activating factor using HPLC-tandem mass spectrometry. Owen JS; Wykle RL; Samuel MP; Thomas MJ J Lipid Res; 2005 Feb; 46(2):373-82. PubMed ID: 15520455 [TBL] [Abstract][Full Text] [Related]
17. Species-specific variations in the molecular heterogeneity of the platelet-activating factor. Ramesha CS; Pickett WC J Immunol; 1987 Mar; 138(5):1559-63. PubMed ID: 3100641 [TBL] [Abstract][Full Text] [Related]
18. Biosynthesis and release of platelet-activating factor from human monocytes. Camussi G; Bussolino F; Tetta C; Piacibello W; Aglietta M Int Arch Allergy Appl Immunol; 1983 Mar; 70(3):245-51. PubMed ID: 6826235 [TBL] [Abstract][Full Text] [Related]
19. Hydroxyl-platelet-activating factor exists in blood of healthy volunteers and periodontal patients. Antonopoulou S; Tsoupras A; Baltas G; Kotsifaki H; Mantzavinos Z; Demopoulos CA Mediators Inflamm; 2003 Aug; 12(4):221-7. PubMed ID: 14514473 [TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of platelet activating factor treated with pentafluorobenzoyl chloride using gas chromatography/negative ion chemical ionization mass spectrometry. Shindo K; Hashimoto Y Drugs Exp Clin Res; 1991; 17(7):343-9. PubMed ID: 1794300 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]